US Greenlights Novartis' $2.9B MorphoSys Takeover
By Al Barbarino · March 22, 2024, 3:10 PM EDT
Germany's MorphoSys AG said Friday it has received U.S. antitrust clearance for the biopharmaceutical company's planned $2.9 billion sale to Swiss Pharma giant Novartis AG, a development that clears the final...
To view the full article, register now.